The DOI matches its Crossref record.
A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.
Abstract
The subunit composition and pharmacological regulation of rat neuronal nicotinic cholinergic receptors were assessed. Specific immunoprecipitation was determined in solubilized rat brain homogenates using [3H]cytisine, a high affinity agonist at nicotinic receptors, in conjunction with polyclonal antisera generated against nonhomologous domains of the various subunits comprising this receptor class. In all brain regions tested, only antisera generated against the alpha 4 and beta 2 subunits were able to immunoprecipitate specifically receptors labeled by [3H]cytisine. Thus, these sera were further characterized in order to validate and optimize their use in the immunoprecipitation protocol. Preincubation of solubilized receptors from rat forebrain with antisera generated against the alpha 2, alpha 3, alpha 5, beta 3, or beta 4 subunits did not decrease the amount of precipitable alpha 4 or beta 2 subunit. On the other hand, when either anti-alpha 4 or anti-beta 2 serum was used to immunoprecipitate solubilized receptors from rat forebrain, the supernatants contained little if any remaining receptors that could be specifically precipitated by either antibody. Because these antisera do not cross-react, the data indicate that alpha 4 and beta 2 subunits are associated with each other in at least one neuronal nicotinic receptor subtype that has high affinity for agonists. Moreover, these results imply that all alpha 4 subunits that are labeled by [3H]cystisine are coupled to beta 2 subunits. We also present evidence that the alpha 4/beta 2 subtype characterized in this report is significantly increased in the cortex of rats chronically treated with nicotine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, nicotine induced increases in nAChR, termed “upregulation”, are conferred by a specific microdomain that is in the β2-subunit 34 and thus this upregulation is confined to nAChR that contain the β2-subunit4, 19, 31, 35-38.”
From β2-Nicotinic Acetylcholine Receptor Availability During Acute and Prolonged Abstinence From Tobacco Smoking (2009) · cites this paper as [19]
In the citing paper
“Immunoprecipitation with subunit-selective antibodies and studies in genetic knockout models demonstrate that chronic administration of nicotine increases predominantly the ␣42 subtype of nAChRs in rodent brain (Flores et al., 1992;Mao et al., 2008;Moretti et al., 2010;Marks et al., 2011)”
From Chronic Sazetidine-A at Behaviorally Active Doses Does Not Increase Nicotinic Cholinergic Receptors in Rodent Brain (2012) · cites this paper as Flores et al., 1992
Citations
Cited by
Sorted by citations
Items 601–700 of 880
The α4 subunit of rat α4β2 nicotinic receptors is phosphorylated in vivo
Viseshakul, N., Figl, A., Lytle, C. Y., & Cohen, B. N. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00128-4 · Cited by 19
Yohannes, D., Procko, K., Lebel, L. A., Fox, C. B., & O’Neill, B. T. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.02.078 · Cited by 19
Nicotinic Receptor Intervention in Parkinson's Disease: Future Directions.
Tizabi, Y., & Getachew, B. (2017) · PubMed · Cited by 19
Discriminative Stimulus (DS) Properties of Nicotine in the C57BL/6 Mouse
Varvel, S. A., James, J. R., Bowen, S. E., Rosecrans, J. A., & Karan, L. D. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00262-7 · Cited by 18
Awtry, T. L., Frank, J. G., & Werling, L. L. (2006) · Synapse · doi:10.1002/syn.20251 · Cited by 19
Analysis of nicotinic acetylcholine receptor subunits in the cochlea of the mouse
Drescher, D. G., Khan, K. M., Green, G. E., Morley, B. J., Beisel, K. W., Kaul, H., Gordon, D., Gupta, A. K., Drescher, M. J., & Barretto, R. L. (1995) · Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology · doi:10.1016/0742-8413(95)02020-9 · Cited by 19
Nishizaki, T., Matsuoka, T., Nomura, T., Kondoh, T., Watabe, S., Shiotani, T., & Yoshii, M. (2000) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200000001-00013 · Cited by 19
Yu, K., Liu, Q., Wu, J., & Lukas, R. J. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.48 · Cited by 18
Covernton, P. J. O., & Lester, R. A. J. (2002) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(02)00036-9 · Cited by 18
Tumor Necrosis Factor α Enhances Nicotinic Receptor Up-regulation via a p38MAPK-dependent Pathway
Gahring, L. C., Osborne-Hereford, A. V., Vasquez-Opazo, G. A., & Rogers, S. W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707330200 · Cited by 18
Pradhan, A. A. A., Cumming, P. D., & Clarke, P. B. S. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03340-1 · Cited by 17
Corticosterone reversibly alters brain α-bungarotoxin binding and nicotine sensitivity
Grun, E. U., Pauly, J. R., Bullock, A. E., & Collins, A. C. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00157-r · Cited by 18
The most cited authors and papers in tobacco control
Byrne, F., & Chapman, S. F. (2005) · Tobacco Control · doi:10.1136/tc.2005.011973 · Cited by 18
New functions for nicotinic acetylcholine receptors?
Steinlein, O. K. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00207-6 · Cited by 18
Klimaschewski, L. P., Reuss, S., Spessert, R., Lobron, C., Wevers, A., Heym, C., Maelicke, A., & Schröder, H. C. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90199-6 · Cited by 18
Wevers, A., Sullivan, J. P., Giordano, T., Birtsch, C., Monteggia, L. M., Nowacki, S., Arnerić, S. P., & Schröder, H. C. (1995) · Drug Development Research · doi:10.1002/ddr.430360205 · Cited by 18
Slotkin, T. A., & Seidler, F. J. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.12.003 · Cited by 17
Nicotine increases cytosolic Ca 2+in vasopressin neurons
Shioda, S., Yada, T., Muroya, S., Takigawa, M., & Nakai, Y. (1997) · Neuroscience Research · doi:10.1016/s0168-0102(97)00103-x · Cited by 17
Laikowski, M. M., Reisdorfer, F., & Moura, S. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180410105135 · Cited by 17
Opposing actions of chronic stress and chronic nicotine on striatal function in mice
Salas, R., & Biasi, M. D. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.05.038 · Cited by 17
Böhme, G. A., Letchworth, S. R., Piot, O., Gatto, G. J., Obinu, M. C., Caldwell, W. S., Laville, M., Brunel, P., Pellerin, R., Leconte, J., et al. (2004) · Drug Development Research · doi:10.1002/ddr.10352 · Cited by 17
Varas, R., Valdés, V., Iturriaga‐Vásquez, P., Cassels, B. K., Iturriaga, R., & Alcayaga, J. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.006 · Cited by 17
Rao, T. S., Adams, P. B., Correa, L. D., Santori, E. M., Sacaan, A. I., Reid, R. T., Suto, C. M., & Vernier, J. M. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02979-2 · Cited by 17
Cholinergic regulation of synaptic plasticity as a therapeutic target in Alzheimer's disease
Small, D. H., & Fodero, L. R. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4502 · Cited by 17
Luetje, C. W., Maddox, F. N., & Harvey, S. C. (1998) · PubMed · Cited by 17
Regulation of ion channel expression in neural cells by hormones and growth factors
Chew, L., & Gallo, V. (1998) · Molecular Neurobiology · doi:10.1007/bf02741300 · Cited by 17
Auta, J., Lecca, D., Nelson, M., Guidotti, A., Overstreet, D. H., Costa, E., & Javaid, J. I. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00082-4 · Cited by 17
The effect of nicotine and haloperidol co-treatment on nicotinic receptor levels in the rat brain
Lee, M. J., Breese, C. R., Strook, M. L., & Leonard, S. S. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00274-6 · Cited by 17
Quantitative changes of nicotinic receptors in the hippocampus of dystrophin-deficient mice
Ghedini, P. C., Avellar, M. C. W., de Lima, T. C. M., Lima‐Landman, M. T. R., Lapa, A. J., & Souccar, C. (2012) · Brain Research · doi:10.1016/j.brainres.2012.09.021 · Cited by 16
Simmons, S. J., & Gould, T. J. (2014) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12171 · Cited by 18
Neurotransmitter regulation of neural development: acetylcholine and nicotinic receptors
Torrão, A. D. S., & Britto, L. R. G. (2002) · Anais da Academia Brasileira de Ciências · doi:10.1590/s0001-37652002000300008 · Cited by 16
Lü, Y., Marks, M. J., & Collins, A. C. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35218-8 · Cited by 40
Hussmann, G. P., Yasuda, R. P., Xiao, Y., Wolfe, B. B., & Kellar, K. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.289546 · Cited by 16
Quantitative analysis of the heteromeric neuronal nicotinic receptors in the rat hippocampus
Lomazzo, E., MacArthur, L. H., Yasuda, R. P., Wolfe, B. B., & Kellar, K. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06967.x · Cited by 15
Pubill, D., Garcia‐Ratés, S., Camarasa, J., & Escubedo, E. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.11.008 · Cited by 15
Schneider, K. K., Schote, A. B., Meyer, J., Markett, S. A., Reuter, M., & Frings, C. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.01.041 · Cited by 16
Hamouda, A. K., Bautista, M. R., Akinola, L. S., Alkhlaif, Y., Jackson, A. B., Carper, M., Toma, W. B., Garai, S., Chen, Y.-C., Thakur, G. A., et al. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108568 · Cited by 15
Smith, A. M., Pivavarchyk, M., Wooters, T. E., Zhang, Z., Zheng, G., McIntosh, J. M., Crooks, P. A., Bardo, M. T., & Dwoskin, L. P. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.03.018 · Cited by 15
Human α4β2 Nicotinic Acetylcholine Receptor as a Novel Target of Oligomeric α-Synuclein
Liu, Q., Emadi, S., Shen, J., Sierks, M. R., & Wu, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055886 · Cited by 15
Filchakova, O., & McIntosh, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064655 · Cited by 15
McClure‐Begley, T. D., Grady, S. R., Marks, M. J., Collins, A. C., & Stitzel, J. A. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.06.010 · Cited by 15
Choline Promotes Nicotinic Receptor α4 + β2 Up-regulation
Gahring, L. C., Vasquez-Opazo, G. A., & Rogers, S. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.108803 · Cited by 16
Abreu‐Villaça, Y., Correa‐Santos, M., Dutra-Tavares, A. C., Paes‐Branco, D., Nunes‐Freitas, A. L., Manhães, A. C., Filgueiras, C. C., & Ribeiro‐Carvalho, A. (2016) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2016.06.002 · Cited by 15
Molecular, Neuronal, and Behavioral Effects of Ethanol and Nicotine Interactions
Klenowski, P. M., & Tapper, A. R. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2017_89 · Cited by 15
Ochoa, E. L. M., & O'Shea, S. M. (1994) · Cellular and Molecular Neurobiology · doi:10.1007/bf02088714 · Cited by 15
Determinants of Agonist Binding Affinity on Neuronal Nicotinic Receptor β Subunits
Parker, M. J., Harvey, S. C., & Luetje, C. W. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29341-1 · Cited by 15
Slotkin, T. A., Freibaum, B. D., Tate, C. A., Thillai, I., Ferguson, S. A., Cada, A. M., & Seidler, F. J. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02993-7 · Cited by 15
Interactions between tachykinins and diverse, human nicotinic acetylcholine receptor subtypes
Lukas, R. J., & Eisenhour, C. M. (1996) · Neurochemical Research · doi:10.1007/bf02532402 · Cited by 15
Expression of α4-1 and α5 Nicotinic Cholinoceptor mRNA in the Aging Rat Cerebral Cortex
Birtsch, C. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)80316-8 · Cited by 15
Bednar, I., Zhang, X., Dastranj‐sedghi, R., & Nordberg, A. K. (1998) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(98)00076-8 · Cited by 15
Alkyl‐modified side chain variants of anatoxin‐a: A series of potent nicotinic agonists
Thomas, P., Brough, P. A., Gallagher, T. C., & Wonnacott, S. (1994) · Drug Development Research · doi:10.1002/ddr.430310210 · Cited by 15
Hamouda, A. K., Jackson, A. B., Bağdaş, D., & Damaj, M. I. (2017) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntx183 · Cited by 14
In vitro and in vivo characterization of a novel negative allosteric modulator of neuronal nAChRs
Abdrakhmanova, G. R., Blough, B. E., Nesloney, C., Navarro, H. A., Damaj, M. I., & Carroll, F. I. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.006 · Cited by 14
Lidocaine effects on acetylcholine-elicited currents from mouse superior cervical ganglion neurons.
Alberola-Die, A., Reboreda, A., Lamas, J. A., & Morales, A. (2013) · Neurosciences research · doi:10.1016/j.neures.2013.01.005 · Cited by 14
Schochet, T. L., Bremer, Q. Z., Brownfield, M. S., Kelley, A. E., & Landry, C. F. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06483.x · Cited by 14
Kirsch, G. E., Fedorov, N. B., Kuryshev, Y. A., Liu, Z., Armstrong, L. C., & Orr, M. S. (2016) · Assay and Drug Development Technologies · doi:10.1089/adt.2015.688 · Cited by 14
Nicotinic Acetylcholine Receptors of PC12 Cells
Mussina, K., Toktarkhanova, D., & Filchakova, O. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00846-x · Cited by 15
Design of novel nicotinic ligands through 3D database searching
Guandalini, L., Martini, E., Dei, S., Manetti, D., Scapecchi, S., Teodori, E., Romanelli, M. N., Varani, K., Greco, G., Spadola, L., et al. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.10.039 · Cited by 14
Pharmacology of neuronal nicotinic acetylcholine receptors: Effect of acute and chronic nicotine
Kellar, K. J., Dávila‐García, M. I., & Xiao, Y. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050011921 · Cited by 14
Chorvat, R. J., Zaczek, R. C., & Brown, B. S. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.4.499 · Cited by 14
Nicotine Addiction: Past and Present
Office on Smoking (2010) · Cited by 14
Papke, R. L., Zheng, G., Horenstein, N. A., Dwoskin, L. P., & Crooks, P. A. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.05.118 · Cited by 14
Lin, N., Abreo, M. A., Gunn, D., Lebold, S. A., Lee, E. L., Wasicak, J. T., Hettinger, A.-M., Daanen, J. F., Garvey, D. S., Campbell, J. E., et al. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00462-x · Cited by 14
Calcium Modulation of Activation and Desensitization of Nicotinic Receptors from Mouse Brain
Booker, T. K., Smith, K. W., Dodrill, C., & Collins, A. C. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71041490.x · Cited by 14
Woodruff‐Pak, D. S. (1995) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1995.tb00279.x · Cited by 14
Zhang, X., Gong, Z., Fasth, K. J., Långström, B., & Nordberg, A. K. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(97)00119-8 · Cited by 14
Liu, Y., Richardson, J. R., Tran, T. P., Al‐Muhtasib, N., Xie, T., Yenugonda, V. M., Sexton, H. G., Rezvani, A. H., Levin, E. D., Sahibzada, N., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4000374 · Cited by 13
Slotkin, T. A., Ryde, I. T., & Seidler, F. J. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.11.003 · Cited by 13
Rezvani, A. H., Timofeeva, O., Sexton, H. G., DeCuir, D., Xiao, Y., Gordon, C. J., Kellar, K. J., & Levin, E. D. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.02.031 · Cited by 13
Pharmacogenetics and Smoking Cessation with Nicotine Replacement Therapy
Ray, R., Schnoll, R. A., & Lerman, C. E. (2007) · CNS Drugs · doi:10.2165/00023210-200721070-00001 · Cited by 14
Huang, L. Z., & Winzer‐Serhan, U. H. (2006) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2005.11.008 · Cited by 13
Kobayashi, H., Suzuki, T., Kamata, R., Saito, S., Sato, I., Tsuda, S., & Matsusaka, N. (1999) · The Journal of Toxicological Sciences · doi:10.2131/jts.24.1 · Cited by 13
Lin, N., Dong, L., Bunnelle, W. H., Anderson, D. J., & Meyer, M. D. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00740-0 · Cited by 13
Neuronal Nicotinic Receptor Structure and Function
Lindstrom, J. M., Anand, R., Peng, X.-D., & Gerzanich, V. (1995) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7445-8_6 · Cited by 13
Gahring, L. C., & Rogers, S. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.105346 · Cited by 12
Romano, E., Angelis, F. D., Ulbrich, L., Jaco, A. D., Fuso, A., & Laviola, G. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3388-y · Cited by 14
Slotkin, T. A., Card, J., Infante, A., & Seidler, F. J. (2013) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2013.02.002 · Cited by 12
Madsen, H. B., Koghar, H. S., Pooters, T., Massalas, J. S., Drago, J., & Lawrence, A. J. (2014) · Addiction Biology · doi:10.1111/adb.12148 · Cited by 15
Esterlis, I., Hillmer, A. T., Bois, F., Pittman, B. P., McGovern, E. M., O’Malley, S. S., Picciotto, M. R., Yang, B., Gelernter, J. E., & Cosgrove, K. (2016) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntw081 · Cited by 14
Kimura, I. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)00113-7 · Cited by 12
Sorger, D., Becker, G., Hauber, K., Schildan, A., Patt, M., Birkenmeier, G., Otto, A., Meyer, P., Kluge, M., Schliebs, R., et al. (2006) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2006.07.012 · Cited by 12
miRNAome analysis of the mammalian neuronal nicotinic acetylcholine receptor gene family
Hogan, E. M., Casserly, A. P., Scofield, M. D., Mou, Z., Zhao-Shea, R., Johnson, C. W., Tapper, A. R., & Gardner, P. D. (2014) · RNA · doi:10.1261/rna.034066.112 · Cited by 13
Galantamine may improve attention and speech in schizophrenia
Ochoa, E. L. M., & Clark, E. W. (2006) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.751 · Cited by 12
Synthesis of no-carrier-added [18F]fluoroacetate
Jeong, J. M., Lee, D. S., Chung, J., Lee, M. C., Koh, C., & Kang, S. S. (1997) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/(sici)1099-1344(199705)39:5 · Cited by 16
Zhang, X., Paterson, D., James, R. P., Gong, Z., Liu, C., Rosecrans, J. A., & Nordberg, A. K. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00205-9 · Cited by 12
Depression, smoking, and nicotine: Toward a bioinformational situation by trait model
Gilbert, D. G. (1996) · Drug Development Research · doi:10.1002/(sici)1098-2299(199607/08)38:3/4 · Cited by 25
New medications development for smoking cessation
Lengel, D., & Kenny, P. J. (2023) · Addiction Neuroscience · doi:10.1016/j.addicn.2023.100103 · Cited by 14
Zambrano, C. A., Marks, M. J., Cassels, B. K., & Maccioni, R. B. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.05.004 · Cited by 11
McClure‐Begley, T. D., Wageman, C. R., Grady, S. R., Marks, M. J., McIntosh, J. M., Collins, A. C., & Whiteaker, P. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07759.x · Cited by 11
Dwoskin, L. P., Pivavarchyk, M., Joyce, B. M., Neugebauer, N. M., Zheng, G., Zhang, Z., Bardo, M. T., & Crooks, P. A. (2008) · Nebraska Symposium on Motivation/The Nebraska symposium on motivation · doi:10.1007/978-0-387-78748-0_4 · Cited by 12
Chen, Y.-H., Lin, B., Hsieh, T.-H., Kuo, T., Miller, J., Chou, Y., Huang, E. Y., & Hoffer, B. J. (2018) · Cell Transplantation · doi:10.1177/0963689718775382 · Cited by 12
Llabrés, S., Garcia‐Ratés, S., Cristóbal‐Lecina, E., Riéra, A., Borrell, J. I., Camarasa, J., Pubill, D., Luque, F. J., & Escubedo, E. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.044 · Cited by 11
MacPhail, R. C., Farmer, J. D., & Jarema, K. A. (2007) · Toxicology · doi:10.1016/j.tox.2007.02.001 · Cited by 11
Stitzel, J. A., Farnham, D. A., & Collins, A. C. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00584-6 · Cited by 11
Characterization of nicotinic receptors in immortalized hippocampal neurons
Komourian, J., & Quik, M. (1996) · Brain Research · doi:10.1016/0006-8993(96)00024-8 · Cited by 11
Yohannes, D., Hansen, C. P., Akireddy, S. R., Hauser, T. A., Kiser, M. N., Gurnon, N. J., Day, C. S., Bhatti, B. S., & Caldwell, W. S. (2008) · Organic Letters · doi:10.1021/ol802145b · Cited by 11
Recent advances in gene manipulation and nicotinic acetylcholine receptor biology
Tammimäki, A., Horton, W. J., & Stitzel, J. A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.014 · Cited by 10
5-HT2A and 5-HT2C receptors as potential targets for the treatment of nicotine use and dependence
Higgins, G. A., & Sellers, E. M. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.01.007 · Cited by 10
Clark, C. G., Sun, Z., Meininger, G. A., & Potts, J. T. (2012) · Experimental Physiology · doi:10.1113/expphysiol.2012.067660 · Cited by 10
Nair, L. R., & Liu, X. (2019) · PubMed · Cited by 10
Metadata
- Authors
- Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J.
- Affiliations
- Georgetown University Medical Center (US)
- University of Colorado Denver (US)
- Georgetown University (US)
- ORCID
- Kellar, K J
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 1992-01
- Volume
- 41
- Issue
- 1
- Pages
- 31-37
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2116249462
- Cited by
- 880
- References
- 0
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 7 · 2021: 7 · 2020: 7 · 2019: 10 · 2018: 7 · 2017: 9 · 2016: 18 · 2015: 25 · 2014: 25 · 2013: 22 · 2012: 21
- FWCI
- 8.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Funders
- National Institutes of Health (5r01ag009884-05, 5r01da006486-10, 5r01ns011549-24)
- National Institute on Aging (AG 09884)
- National Institute on Drug Abuse (DA-06486)
- National Institute of Neurological Disorders and Stroke (NS11549)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, receptor subunit composition, chronic nicotine treatment, receptor up-regulation, rat cortex, forebrain, neuronal nicotinic receptors
- MeSH terms
- Quinolizidine Alkaloids, Alkaloids, Animals, Antibodies, Azocines, Brain, Kinetics, Male, Nicotine, Precipitin Tests, Quinolizines, Rats, Inbred Strains, Receptors, Nicotinic, Time Factors, Tritium, Up-Regulation, Macromolecular Substances, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review